Unknown PHASE2 INTERVENTIONAL 2-arm NCT00569088

Study of the Pathogenesis and Molecular Mechanism of YURE in Internal Intractable Diseases

973 Project for Pathology of Traditional Chinese Medicine

Sponsor: Nanjing University of Traditional Chinese Medicine

Conditions Stroke

Interventions Chinese herbs formula Mannitol

Updated 5 times since 2017 Last updated: Jul 7, 2009 Started: Nov 30, 2007 Primary completion: Apr 30, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Stroke and is currently ongoing. Nanjing University of Traditional Chinese Medicine leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nanjing University of Traditional Chinese Medicine

Data source: Nanjing University of Traditional Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China